{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T11:31:25Z","timestamp":1773142285728,"version":"3.50.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100003494","name":"Herzfelder'sche Familienstiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003494","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12933-017-0579-6","type":"journal-article","created":{"date-parts":[[2017,8,8]],"date-time":"2017-08-08T09:58:20Z","timestamp":1502186300000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Neutrophil gelatinase associated lipocalin (NGAL) is elevated in type 2 diabetics with carotid artery stenosis and reduced under metformin treatment"],"prefix":"10.1186","volume":"16","author":[{"given":"W.","family":"Eilenberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Stojkovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Piechota-Polanczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Kaider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Kozakowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. J.","family":"Weninger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Nanobachvili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Wojta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Huk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Demyanets","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Neumayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,8,8]]},"reference":[{"issue":"10","key":"579_CR1","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/nrendo.2016.105","volume":"12","author":"P Zimmet","year":"2016","unstructured":"Zimmet P, Alberti KG, Magliano DJ, Bennett PH. Diabetes mellitus statistics on prevalence and mortality: facts and fallacies. Nat Rev Endocrinol. 2016;12(10):616\u201322.","journal-title":"Nat Rev Endocrinol."},{"issue":"19","key":"579_CR2","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1001\/jama.1979.03290450033020","volume":"241","author":"WB Kannel","year":"1979","unstructured":"Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA. 1979;241(19):2035\u20138.","journal-title":"JAMA"},{"issue":"9733","key":"579_CR3","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/S0140-6736(10)60484-9","volume":"375","author":"N Sarwar","year":"2010","unstructured":"Sarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S, Di Angelantonio E, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375(9733):2215\u201322.","journal-title":"Lancet"},{"issue":"2","key":"579_CR4","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S2213-8587(14)70219-0","volume":"3","author":"AD Shah","year":"2015","unstructured":"Shah AD, Langenberg C, Rapsomaniki E, Denaxas S, Pujades-Rodriguez M, Gale CP, et al. Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1.9 million people. Lancet Diabetes Endocrinol. 2015;3(2):105\u201313.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"579_CR5","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s10353-011-0607-9","volume":"43","author":"S Demyanets","year":"2011","unstructured":"Demyanets S, Huber K, Wojta J. Inflammation and the cardiovascular system. Eur Surg. 2011;43(2):78\u201389.","journal-title":"Eur Surg."},{"issue":"12","key":"579_CR6","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.acvd.2016.04.002","volume":"109","author":"S Taleb","year":"2016","unstructured":"Taleb S. Inflammation in atherosclerosis. Arch Cardiovasc Dis. 2016;109(12):708\u201315.","journal-title":"Arch Cardiovasc Dis"},{"key":"579_CR7","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.atherosclerosis.2016.08.011","volume":"253","author":"A Pircher","year":"2016","unstructured":"Pircher A, Treps L, Bodrug N, Carmeliet P. Endothelial cell metabolism: a novel player in atherosclerosis? Basic principles and therapeutic opportunities. Atherosclerosis. 2016;253:247\u201357.","journal-title":"Atherosclerosis."},{"issue":"7","key":"579_CR8","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1160\/TH16-10-0784","volume":"117","author":"S Stojkovic","year":"2017","unstructured":"Stojkovic S, Thulin A, Hell L, Thaler B, Rauscher S, Baumgartner J, et al. IL-33 stimulates the release of procoagulant microvesicles from human monocytes and differentially increases tissue factor in human monocyte subsets. Thromb Haemost. 2017;117(7):1379\u201390.","journal-title":"Thromb Haemost"},{"issue":"2","key":"579_CR9","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1160\/TH15-12-0917","volume":"116","author":"E Montanari","year":"2016","unstructured":"Montanari E, Stojkovic S, Kaun C, Lemberger CE, de Martin R, Rauscher S, et al. Interleukin-33 stimulates GM-CSF and M-CSF production by human endothelial cells. Thromb Haemost. 2016;116(2):317\u201327.","journal-title":"Thromb Haemost"},{"key":"579_CR10","doi-asserted-by":"crossref","first-page":"25171","DOI":"10.1038\/srep25171","volume":"6","author":"S Stojkovic","year":"2016","unstructured":"Stojkovic S, Kaun C, Basilio J, Rauscher S, Hell L, Krychtiuk KA, et al. Tissue factor is induced by interleukin-33 in human endothelial cells: a new link between coagulation and inflammation. Sci Rep. 2016;6:25171.","journal-title":"Sci Rep."},{"issue":"6","key":"579_CR11","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1111\/jth.12581","volume":"12","author":"S Stojkovic","year":"2014","unstructured":"Stojkovic S, Kaun C, Heinz M, Krychtiuk KA, Rauscher S, Lemberger CE, et al. Interleukin-33 induces urokinase in human endothelial cells\u2013possible impact on angiogenesis. J Thromb Haemost. 2014;12(6):948\u201357.","journal-title":"J Thromb Haemost"},{"issue":"9","key":"579_CR12","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1161\/ATVBAHA.111.231431","volume":"31","author":"S Demyanets","year":"2011","unstructured":"Demyanets S, Konya V, Kastl SP, Kaun C, Rauscher S, Niessner A, et al. Interleukin-33 induces expression of adhesion molecules and inflammatory activation in human endothelial cells and in human atherosclerotic plaques. Arterioscler Thromb Vasc Biol. 2011;31(9):2080\u20139.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"579_CR13","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1177\/1479164113500680","volume":"10","author":"AC Roberts","year":"2013","unstructured":"Roberts AC, Porter KE. Cellular and molecular mechanisms of endothelial dysfunction in diabetes. Diab Vasc Dis Res. 2013;10(6):472\u201382.","journal-title":"Diab Vasc Dis Res."},{"issue":"31","key":"579_CR14","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1093\/eurheartj\/eht149","volume":"34","author":"F Paneni","year":"2013","unstructured":"Paneni F, Beckman JA, Creager MA, Cosentino F. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Eur Heart J. 2013;34(31):2436\u201343.","journal-title":"Eur Heart J"},{"key":"579_CR15","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12933-016-0369-6","volume":"15","author":"AO Odegaard","year":"2016","unstructured":"Odegaard AO, Jacobs DR Jr, Sanchez OA, Goff DC Jr, Reiner AP, Gross MD. Oxidative stress, inflammation, endothelial dysfunction and incidence of type 2 diabetes. Cardiovasc Diabetol. 2016;15:51.","journal-title":"Cardiovasc Diabetol."},{"issue":"9","key":"579_CR16","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1161\/01.CIR.0000086014.80477.0D","volume":"108","author":"F Cipollone","year":"2003","unstructured":"Cipollone F, Iezzi A, Fazia M, Zucchelli M, Pini B, Cuccurullo C, et al. The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic control. Circulation. 2003;108(9):1070\u20137.","journal-title":"Circulation"},{"issue":"12","key":"579_CR17","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1161\/01.ATV.0000249630.02085.12","volume":"26","author":"C Cuccurullo","year":"2006","unstructured":"Cuccurullo C, Iezzi A, Fazia ML, De Cesare D, Di Francesco A, Muraro R, et al. Suppression of RAGE as a basis of simvastatin-dependent plaque stabilization in type 2 diabetes. Arterioscler Thromb Vasc Biol. 2006;26(12):2716\u201323.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"579_CR18","doi-asserted-by":"crossref","first-page":"630","DOI":"10.2143\/AC.61.6.2017962","volume":"61","author":"R Marfella","year":"2006","unstructured":"Marfella R, Cacciapuoti F, Grassia A, Manfredi E, De Maio G, Caruso G, et al. Role of the ubiquitin\u2013proteasome system in carotid plaque instability in diabetic patients. Acta Cardiol. 2006;61(6):630\u20136.","journal-title":"Acta Cardiol"},{"issue":"1","key":"579_CR19","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.bbrc.2007.08.134","volume":"363","author":"YJ Zhou","year":"2007","unstructured":"Zhou YJ, Wang JH, Li L, Yang HW, de Wen L, He QC. Expanding expression of the 5-lipoxygenase\/leukotriene B4 pathway in atherosclerotic lesions of diabetic patients promotes plaque instability. Biochem Biophys Res Commun. 2007;363(1):30\u20136.","journal-title":"Biochem Biophys Res Commun"},{"issue":"9","key":"579_CR20","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1161\/ATVBAHA.111.229583","volume":"31","author":"Y Gong","year":"2011","unstructured":"Gong Y, Fan Y, Hoover-Plow J. Plasminogen regulates stromal cell-derived factor-1\/CXCR4-mediated hematopoietic stem cell mobilization by activation of matrix metalloproteinase-9. Arterioscler Thromb Vasc Biol. 2011;31(9):2035\u201343.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"9","key":"579_CR21","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1172\/JCI32750","volume":"118","author":"Y Gong","year":"2008","unstructured":"Gong Y, Hart E, Shchurin A, Hoover-Plow J. Inflammatory macrophage migration requires MMP-9 activation by plasminogen in mice. J Clin Invest. 2008;118(9):3012\u201324.","journal-title":"J Clin Invest."},{"issue":"38","key":"579_CR22","doi-asserted-by":"crossref","first-page":"22565","DOI":"10.1074\/jbc.270.38.22565","volume":"270","author":"Q Liu","year":"1995","unstructured":"Liu Q, Nilsen-Hamilton M. Identification of a new acute phase protein. J Biol Chem. 1995;270(38):22565\u201370.","journal-title":"J Biol Chem"},{"issue":"5","key":"579_CR23","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ejvs.2016.01.009","volume":"51","author":"W Eilenberg","year":"2016","unstructured":"Eilenberg W, Stojkovic S, Piechota-Polanczyk A, Kaun C, Rauscher S, Groger M, et al. Neutrophil gelatinase-associated lipocalin (NGAL) is associated with symptomatic carotid atherosclerosis and drives pro-inflammatory state in vitro. Eur J Vasc Endovasc Surg. 2016;51(5):623\u201331.","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"579_CR24","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2017-0156","author":"W Eilenberg","year":"2017","unstructured":"Eilenberg W, Stojkovic S, Kaider A, Kozakowski N, Domenig CM, Burghuber C, et al. NGAL and MMP-9\/NGAL as biomarkers of plaque vulnerability and targets of statins in patients with carotid atherosclerosis. Clin Chem Lab Med. 2017. doi: 10.1515\/cclm-2017-0156 .","journal-title":"Clin Chem Lab Med"},{"issue":"1","key":"579_CR25","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1161\/01.ATV.0000193567.88685.f4","volume":"26","author":"AL Hemdahl","year":"2006","unstructured":"Hemdahl AL, Gabrielsen A, Zhu C, Eriksson P, Hedin U, Kastrup J, et al. Expression of neutrophil gelatinase-associated lipocalin in atherosclerosis and myocardial infarction. Arterioscler Thromb Vasc Biol. 2006;26(1):136\u201342.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"579_CR26","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1189\/jlb.1106671","volume":"82","author":"A Leclercq","year":"2007","unstructured":"Leclercq A, Houard X, Philippe M, Ollivier V, Sebbag U, Meilhac O, et al. Involvement of intraplaque hemorrhage in atherothrombosis evolution via neutrophil protease enrichment. J Leukoc Biol. 2007;82(6):1420\u20139.","journal-title":"J Leukoc Biol"},{"issue":"3","key":"579_CR27","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1093\/cvr\/cvq340","volume":"89","author":"BC Boekhorst te","year":"2011","unstructured":"te Boekhorst BC, Bovens SM, Hellings WE, van der Kraak PH, van de Kolk KW, Vink A, et al. Molecular MRI of murine atherosclerotic plaque targeting NGAL: a protein associated with unstable human plaque characteristics. Cardiovasc Res. 2011;89(3):680\u20138.","journal-title":"Cardiovasc Res"},{"key":"579_CR28","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1155\/2012\/189797","volume":"2012","author":"N Kafkas","year":"2012","unstructured":"Kafkas N, Demponeras C, Zoubouloglou F, Spanou L, Babalis D, Makris K. Serum levels of gelatinase associated lipocalin as indicator of the inflammatory status in coronary artery disease. Int J Inflam. 2012;2012:189\u2013797.","journal-title":"Int J Inflam."},{"issue":"4","key":"579_CR29","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jacc.2012.04.017","volume":"60","author":"S Lindberg","year":"2012","unstructured":"Lindberg S, Pedersen SH, Mogelvang R, Jensen JS, Flyvbjerg A, Galatius S, et al. Prognostic utility of neutrophil gelatinase-associated lipocalin in predicting mortality and cardiovascular events in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. J Am Coll Cardiol. 2012;60(4):339\u201345.","journal-title":"J Am Coll Cardiol"},{"key":"579_CR30","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2017-0120","author":"Z Sivalingam","year":"2017","unstructured":"Sivalingam Z, Larsen SB, Grove EL, Hvas AM, Kristensen SD, Magnusson NE. Neutrophil gelatinase-associated lipocalin as a risk marker in cardiovascular disease. Clin Chem Lab Med. 2017. doi: 10.1515\/cclm-2017-0120 .","journal-title":"Clin Chem Lab Med"},{"issue":"40","key":"579_CR31","doi-asserted-by":"crossref","first-page":"37258","DOI":"10.1074\/jbc.M106089200","volume":"276","author":"L Yan","year":"2001","unstructured":"Yan L, Borregaard N, Kjeldsen L, Moses MA. The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B\/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL. J Biol Chem. 2001;276(40):37258\u201365.","journal-title":"J Biol Chem"},{"issue":"17","key":"579_CR32","doi-asserted-by":"crossref","first-page":"396","DOI":"10.4239\/wjd.v7.i17.396","volume":"7","author":"R Kumar","year":"2016","unstructured":"Kumar R, Nandhini LP, Kamalanathan S, Sahoo J, Vivekanadan M. Evidence for current diagnostic criteria of diabetes mellitus. World J Diabetes. 2016;7(17):396\u2013405.","journal-title":"World J Diabetes."},{"issue":"39","key":"579_CR33","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1093\/eurheartj\/eht108","volume":"34","author":"L Ryden","year":"2013","unstructured":"Ryden L, Grant PJ, Anker SD, Berne C, Cosentino F, Danchin N, et al. ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J. 2013;34(39):3035\u201387.","journal-title":"Eur Heart J"},{"issue":"4","key":"579_CR34","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1161\/CIR.0b013e31820d8d78","volume":"124","author":"TG Brott","year":"2011","unstructured":"Brott TG, Halperin JL, Abbara S, Bacharach JM, Barr JD, Bush RL, et al. ASA\/ACCF\/AHA\/AANN\/AANS\/ACR\/ASNR\/CNS\/SAIP\/SCAI\/SIR\/SNIS\/SVM\/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease. A report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines, and the American Stroke Association, American Association of Neuroscience Nurses, American Association of Neurological Surgeons, American College of Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of NeuroInterventional Surgery, Society for Vascular Medicine, and Society for Vascular Surgery. Circulation. 2011;124(4):e54\u2013130.","journal-title":"Circulation"},{"issue":"6","key":"579_CR35","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jash.2015.03.002","volume":"9","author":"C Rosendorff","year":"2015","unstructured":"Rosendorff C, Lackland DT, Allison M, Aronow WS, Black HR, Blumenthal RS, et al. Treatment of hypertension in patients with coronary artery disease: a scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension. J Am Soc Hypertens JASH. 2015;9(6):453\u201398.","journal-title":"J Am Soc Hypertens JASH."},{"issue":"5","key":"579_CR36","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1161\/01.ATV.20.5.1177","volume":"20","author":"HC Stary","year":"2000","unstructured":"Stary HC. Natural history and histological classification of atherosclerotic lesions: an update. Arterioscler Thromb Vasc Biol. 2000;20(5):1177\u20138.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"7","key":"579_CR37","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s11883-014-0419-z","volume":"16","author":"F Paneni","year":"2014","unstructured":"Paneni F, Costantino S, Cosentino F. Insulin resistance, diabetes, and cardiovascular risk. Curr Atheroscler Rep. 2014;16(7):419.","journal-title":"Curr Atheroscler Rep."},{"issue":"7","key":"579_CR38","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1515\/CCLM.2010.211","volume":"48","author":"C Giaginis","year":"2010","unstructured":"Giaginis C, Zira A, Katsargyris A, Klonaris C, Theocharis S. Clinical implication of plasma neutrophil gelatinase-associated lipocalin (NGAL) concentrations in patients with advanced carotid atherosclerosis. Clin Chem Lab Med. 2010;48(7):1035\u201341.","journal-title":"Clin Chem Lab Med"},{"issue":"1","key":"579_CR39","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0021-9150(96)06077-7","volume":"131","author":"AM Elneihoum","year":"1997","unstructured":"Elneihoum AM, Falke P, Hedblad B, Lindgarde F, Ohlsson K. Leukocyte activation in atherosclerosis: correlation with risk factors. Atherosclerosis. 1997;131(1):79\u201384.","journal-title":"Atherosclerosis."},{"issue":"1","key":"579_CR40","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1373\/clinchem.2006.075614","volume":"53","author":"Y Wang","year":"2007","unstructured":"Wang Y, Lam KS, Kraegen EW, Sweeney G, Zhang J, Tso AW, et al. Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans. Clin Chem. 2007;53(1):34\u201341.","journal-title":"Clin Chem"},{"issue":"9","key":"579_CR41","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1161\/ATVBAHA.114.303950","volume":"34","author":"S Lindberg","year":"2014","unstructured":"Lindberg S, Jensen JS, Mogelvang R, Pedersen SH, Galatius S, Flyvbjerg A, et al. Plasma neutrophil gelatinase-associated lipocalin in the general population: association with inflammation and prognosis. Arterioscler Thromb Vasc Biol. 2014;34(9):2135\u201342.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"9","key":"579_CR42","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1515\/cclm-2012-0227","volume":"50","author":"K Makris","year":"2012","unstructured":"Makris K, Rizos D, Kafkas N, Haliassos A. Neutrophil gelatinase-associated lipocalin as a new biomarker in laboratory medicine. Clin Chem Lab Med. 2012;50(9):1519\u201332.","journal-title":"Clin Chem Lab Med"},{"issue":"1","key":"579_CR43","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12933-017-0556-0","volume":"16","author":"M Noh","year":"2017","unstructured":"Noh M, Kwon H, Jung CH, Kwon SU, Kim MS, Lee WJ, et al. Impact of diabetes duration and degree of carotid artery stenosis on major adverse cardiovascular events: a single-center, retrospective, observational cohort study. Cardiovasc Diabetol. 2017;16(1):74.","journal-title":"Cardiovasc Diabetol."},{"issue":"5","key":"579_CR44","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.trsl.2015.06.002","volume":"166","author":"W Xu","year":"2015","unstructured":"Xu W, Deng YY, Yang L, Zhao S, Liu J, Zhao Z, et al. Metformin ameliorates the proinflammatory state in patients with carotid artery atherosclerosis through sirtuin 1 induction. Transl Res. 2015;166(5):451\u20138.","journal-title":"Transl Res."},{"key":"579_CR45","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12933-015-0273-5","volume":"14","author":"DI Bromage","year":"2015","unstructured":"Bromage DI, Yellon DM. The pleiotropic effects of metformin: time for prospective studies. Cardiovasc Diabetol. 2015;14:109.","journal-title":"Cardiovasc Diabetol."},{"issue":"2","key":"579_CR46","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ijcard.2008.04.010","volume":"134","author":"NL Huang","year":"2009","unstructured":"Huang NL, Chiang SH, Hsueh CH, Liang YJ, Chen YJ, Lai LP. Metformin inhibits TNF-alpha-induced IkappaB kinase phosphorylation, IkappaB-alpha degradation and IL-6 production in endothelial cells through PI3K-dependent AMPK phosphorylation. Int J Cardiol. 2009;134(2):169\u201375.","journal-title":"Int J Cardiol"},{"issue":"1","key":"579_CR47","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12933-017-0509-7","volume":"16","author":"A Mary","year":"2017","unstructured":"Mary A, Hartemann A, Liabeuf S, Aubert CE, Kemel S, Salem JE, et al. Association between metformin use and below-the-knee arterial calcification score in type 2 diabetic patients. Cardiovasc Diabetol. 2017;16(1):24.","journal-title":"Cardiovasc Diabetol"},{"key":"579_CR48","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12933-015-0304-2","volume":"14","author":"CS Fung","year":"2015","unstructured":"Fung CS, Wan EY, Wong CK, Jiao F, Chan AK. Effect of metformin monotherapy on cardiovascular diseases and mortality: a retrospective cohort study on Chinese type 2 diabetes mellitus patients. Cardiovasc Diabetol. 2015;14:137.","journal-title":"Cardiovasc Diabetol"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-017-0579-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T23:54:15Z","timestamp":1569974055000},"score":1,"resource":{"primary":{"URL":"http:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-017-0579-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,8]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["579"],"URL":"https:\/\/doi.org\/10.1186\/s12933-017-0579-6","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,8]]},"article-number":"98"}}